EUCTR2006-003391-35-NL进行中(未招募)不适用
Evaluation of the efficacy and safety of unpreserved dexamethasone phosphate 0.1% eye drops (T1910) versus placebo in patients with bilateral treated severe keratoconjunctivitis sicca due to Sjögrens' syndrome
aboratoires THEA0 个研究点开始时间: 2006年7月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Male or female aged from 18 to 75 years old.
- •2.Primary or secondary Sjögren:
- •ØAlready diagnosed by the rheumatologist and the maxillofacial specialist.
- •ØFulfilling the European criteria (Vitali et al 1996)
- •3.Severe dry eye syndrome in BOTH EYES defined by:
- •-Questioning on patient’s feeling: score = 3.
- •-At least two of the following ocular symptoms suggestive of dry eye: burning, stinging, dryness feeling, sandy and/or gritty sensation, light sensitivity, reflex tearing, ocular fatigue, blurred vision (improved by tears substitute).
- •-Schirmer test < 5 mm in 5 min OR BUT < 7 s.
- •-Keratoconjunctivitis defined by a lissamine green score (Van Bijsterveld score) = 4
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Dry eye syndrome primarily related to inflammation of ocular surface
- •2. Contraindications to topic dexamethasone :Glaucoma, IOP steroid responder, Herpes simplex, vaccinia, varicella zoster and most other viral infections of the cornea and conjunctiva, bacterial infections, all lesions with involvement of the corneal epithelium, Tuberculosis, fungal infections, acute purulent infections, which like other diseases caused by micro-organisms, can be masked or aggravated by the presence of steroids
- •3.Eyelid dysfunction : Eyelid malposition, Blepharospasm, Facial paralysis, Severe ocular progressive rosacea/ severe blepharitis
- •4.History WITHIN THE LAST 3 MONTHS before the inclusion visit of : Traumatism, Infection (Viral conjunctivitis / Bacterial conjunctivitis / Staphylococcal blepharitis)
- •5.Any relevant ocular anomaly interfering with ocular surface: chemical burns, corneal distrophy, orbital radiotherapy, etc…….
- •6.Known history of ocular allergy.
- •7. Best corrected far visual acuity (VA) = 1/10.
研究者
相似试验
已完成
不适用
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagusDRKS00003369HSK Wiesbaden60
已完成
不适用
Assessment of the Efficacy and Safety of the Use of Perfectha Deep Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines and Temple HollowingR23.4Changes in skin textureDRKS00029739Sinclair Pharmaceuticals LtdEden HouseLakeside70
已完成
不适用
A prospective study of the efficacy and safety of Denosumab for the prevention of osteoporosis in malignant lymphoma patients treated with prednisolone-containing chemotherapyMalignant LymphomaJPRN-UMIN000012362Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine30
招募中
不适用
A prospective study of the efficacy and safety of preoperative chemotherapy with gemcitabine+nab-paclitaxel therapy for resectable pancreatic body and tail cancer with splenic arteriovenous invasion by image.pancreatic cancerJPRN-UMIN000040948Wakayama medical university49
进行中(未招募)
1 期
A prospective study of the safety and efficacy of the use of a Lipiodol Emulsion for the embolization of inflammatory hypervascularizations observed in patients with articular or abarticular pain in the knee - LipioJoint 1EUCTR2020-002206-10-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)22
